Mackey Rachel H, Mora Samia, Bertoni Alain G, Wassel Christina L, Carnethon Mercedes R, Sibley Christopher T, Goff David C
University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA
Brigham and Women's Hospital, Boston, MA.
Diabetes Care. 2015 Apr;38(4):628-36. doi: 10.2337/dc14-0645. Epub 2015 Jan 15.
In the Multi-Ethnic Study of Atherosclerosis (MESA), we evaluated associations of baseline levels of a lipoprotein-based insulin resistance (IR) index (LP-IR), IR-related lipoprotein particles, mean particle sizes, and lipids, with incident type 2 diabetes, independent of confounders, glucose, insulin, and HOMA-IR.
Among 5,314 adults aged 45-84 years without baseline diabetes or cardiovascular disease, 656 cases of diabetes were identified during a mean follow-up of 7.7 years. Lipoprotein particle concentrations, size, and LP-IR were determined by nuclear magnetic resonance spectroscopy of stored baseline plasma. Potential effect modification, by race/ethnicity, sex, baseline use of lipid-lowering medications or hormone therapy, or glucose strata (<90, 90-99, and ≥ 100 mg/dL), was also evaluated.
Higher levels of LP-IR, large VLDL particles (VLDL-P), small LDL particles, triglycerides (TG), and TG-to-HDL cholesterol (HDL-C) ratio and lower levels of large HDL particles, smaller HDL and LDL size, and larger VLDL size were significantly associated with incident diabetes adjusted for confounders and glucose or insulin. These also were similar by race/ethnicity, sex, and treatment group. Associations were similar for LP-IR, large VLDL-P, mean VLDL size, TG, and TG-to-HDL-C ratio; they persisted for LP-IR, large VLDL-P, or mean VLDL size adjusted for HOMA-IR or TG-to-HDL-C ratio and glucose but not for the TG-to-HDL-C ratio adjusted for LP-IR or for HOMA-IR or insulin if adjusted for LP-IR and glucose.
Among ethnically diverse men and women, LP-IR, large VLDL-P, large VLDL size, TG, and TG-to-HDL-C ratio were associated with incident diabetes independent of established risk factors, glucose, insulin, or HOMA-IR, as well as the use of lipid-lowering medications or hormone therapy.
在动脉粥样硬化多民族研究(MESA)中,我们评估了基于脂蛋白的胰岛素抵抗(IR)指数(LP-IR)、IR相关脂蛋白颗粒、平均颗粒大小和脂质的基线水平与2型糖尿病发病之间的关联,该关联独立于混杂因素、血糖、胰岛素和稳态模型评估胰岛素抵抗(HOMA-IR)。
在5314名年龄在45 - 84岁、无基线糖尿病或心血管疾病的成年人中,在平均7.7年的随访期间确定了656例糖尿病病例。通过对储存的基线血浆进行核磁共振波谱分析来测定脂蛋白颗粒浓度、大小和LP-IR。还评估了种族/民族、性别、基线降脂药物或激素治疗的使用情况或血糖分层(<90、90 - 99和≥100 mg/dL)的潜在效应修正作用。
校正混杂因素、血糖或胰岛素后,较高水平的LP-IR、大极低密度脂蛋白颗粒(VLDL-P)、小低密度脂蛋白颗粒、甘油三酯(TG)以及TG与高密度脂蛋白胆固醇(HDL-C)的比值,和较低水平的大高密度脂蛋白颗粒、较小的高密度脂蛋白和低密度脂蛋白大小以及较大的极低密度脂蛋白大小与糖尿病发病显著相关。在种族/民族、性别和治疗组中这些结果也相似。LP-IR、大VLDL-P、平均VLDL大小、TG以及TG与HDL-C的比值的关联相似;在校正HOMA-IR或TG与HDL-C的比值及血糖后,LP-IR、大VLDL-P或平均VLDL大小的关联仍然存在,但在校正LP-IR或HOMA-IR或胰岛素(如果校正LP-IR和血糖)后,TG与HDL-C的比值的关联不存在。
在不同种族的男性和女性中,LP-IR、大VLDL-P、大VLDL大小、TG以及TG与HDL-C的比值与2型糖尿病发病相关,该关联独立于既定危险因素、血糖、胰岛素或HOMA-IR,以及降脂药物或激素治疗的使用情况。